Lisata Therapeutics LSTA
NASDAQ LSTA
$1.47 -0.02 (-1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lisata Therapeutics (LSTA) Return on Equity [ROE] (2011 - 2026)

Updated

Lisata Therapeutics (LSTA) posted Return on Equity [ROE] of -154.59% for Q2 2026, down 72.09 percentage points from -82.49% a year earlier and down 26.48 percentage points from the prior quarter.

Analysis

Lisata Therapeutics (LSTA) Return on Equity [ROE] (2011 - 2026) Analysis & Trends

For FY2025, Lisata Therapeutics' Return on Equity [ROE] came in at -75.10%, down 23.33 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of -44.26 percentage points (FY2020 to FY2025).
  • In prior years, Lisata Therapeutics' Return on Equity [ROE] was -51.77% in FY2024 (-15.28 pp), -36.49% in FY2023 (+32.01 pp), -68.50% in FY2022 (-24.29 pp) and -44.21% in FY2021 (-13.37 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q1 2017.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last eight quarters, with an average year-over-year change of -38.06 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2024, with a gain of 44.21 percentage points; the weakest was Q2 2026, with a drop of 72.09 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -128.11% (Q1 2026), -102.93% (Q4 2025) and -95.64% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Lisata Therapeutics 13.40 Mn 13.15 Mn - -154.59%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -154.59%
Mar 31, 2026 -128.11%
Dec 31, 2025 -102.93%
Sep 30, 2025 -95.64%
Jun 30, 2025 -82.49%
Mar 31, 2025 -70.96%
Dec 31, 2024 -63.69%
Sep 30, 2024 -58.07%
Jun 30, 2024 -52.20%
Mar 31, 2024 -44.25%
Dec 31, 2023 -41.43%
Sep 30, 2023 -38.88%
Jun 30, 2023 -90.51%
Mar 31, 2023 -88.46%
Dec 31, 2022 -78.53%
Sep 30, 2022 -71.51%
Jun 30, 2022 -28.85%
Mar 31, 2022 -26.22%
Dec 31, 2021 -28.85%
Sep 30, 2021 -25.71%
API Access

Lisata Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=LSTA&period=max&api_key=YOUR_API_KEY